Top

Space OAR Hydrogel

Active

W81K0218T0133Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The U.S. Army MEDCOM's Regional Health Contracting Office-Pacific plans to award a sole source, firm-fixed price contract valued at $71,250 to Augmenix Inc. under solicitation W81K02-18-T-0133 for the purchase of Space OAR Hydrogel, a 10ml injectable implant solution. This product, proprietary to Augmenix Inc., is used in the treatment of prostate and rectal cancers to relieve pain during radiation therapy. The procurement supports the Department of Radiation Oncology at Madigan Army Medical Center in Tacoma, Washington, where the patient's surgeon and the Chief Radiation Therapist have determined this FDA-approved implant best meets patient needs in radiation treatment. The procurement will be conducted using Simplified Acquisition Procedures in accordance with FAR Part 13 and is not a request for proposals; no solicitation will be issued. However, vendors interested in supplying similar products can submit supporting documentation of their products’ capabilities and specifications for consideration in future acquisitions. Communication regarding this procurement should be directed via email only to the designated Purchasing Agent, Walter J. Bischoff, at the provided federal email address. The place of performance is Tacoma, WA, and no telephone or fax inquiries will be accepted.

General Info

Sole source $71,250 contract to Augmenix for Space OAR Hydrogel implant in Tacoma, WA.

Agency

N/A

NAICS

339113 - Surgical Appliance and Supplies Manufacturing

Place of Performance

BLDG# 9040 Fitzsimmons Drive, TACOMA, WA, 98431-5000, USA

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedMar 13

special-notice

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyN/A

Contacts1 person available

OfficeN/A

Organization / Agency

N/A

Office AddressN/A

Contacts

Walter J BischoffPurchasing Agent

contact@example.gov

+1 (555) 000-0000

Full Description

Special Notice to award under Solicitation: W81K02-18-T-0133 Pursuant to FAR Subpart 13.106-1(b) (1), the U.S. Army, MEDCOM, Regional Health Contracting Office-Pacific Joint Base Lewis-McChord, Health Contracting Cell, Lacey, WA, intends to issue a sole source firm-fixed priced award under solicitation W81K02-18-T-0133 to Augmenix Inc. in the amount of $71,250.00 for Space OAR Hydrogel 10ml injectable implant Solution; which will be for use in the treatment of prostate and rectal cancers, as pain relieve during radiation therapy; proprietary to Augmenix Inc., this product will be used by the Department of Radiation Oncology, Madigan Army Medical Center Tacoma WA. The patient's Surgeon & the Chief Radiation Therapist have made the determination that this product will best meet the patient's needs during radiation therapy and be FDA Approved. This notice is not a request for proposal and a solicitation will not be issued. Any vendor that believes it can provide the stated supplies/equipment can provide supporting documents demonstrating their products capability and specifications. Responses received will be used for future acquisitions. Information can be sent to the Purchasing Agent; Mr. Walter J. Bischoff, email; contact@example.gov . No telephone or facsimile requests will be accepted. This procurement will be prepared in accordance with FAR Part 13, using Simplified Acquisition Procedures.

Similar Contracts

Same NAICS industry code